Dexcel Pharma Technologies Ltd. - Insider Trading & Ownership

Location: 1 Dexcel Street, Or Akiva, Israel
Summary: The estimated value of insider holdings of Dexcel Pharma Technologies Ltd. is at least $1.07B dollars as of November 14, 2022. Dexcel Pharma Technologies Ltd. is the 10%+ Owner of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $1.06B. Dexcel Pharma Technologies Ltd. is the 10%+ Owner of Protalix BioTherapeutics, Inc. and owns shares of Protalix BioTherapeutics, Inc. (PLX) stock worth about $5.13M.
Signature: /s/ Dexcel Pharma Technologies Ltd. by Dan Oren, Executive Chairman
All Insider Reports: All Insider Reports

Ownership of Dexcel Pharma Technologies Ltd.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ROIV	Roivant Sciences Ltd.	10%+ Owner	$1.06B			Nov 10, 2022
PLX	Protalix BioTherapeutics, Inc.	10%+ Owner	$5.13M			Jun 2, 2021

Showing 1 to 2 of 2 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.